Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Nabriva hit with FDA rejection of Contempo for complicated urinary tract infections

pharmatimesMay 10, 2019

Tag: Nabriva , FDA , urinary , infection

PharmaSources Customer Service